hb-201,pembrolizumab
merck,hookipa pharma
['pembro', 'hb-201 ', 'hookipa']
hookipa 2-vector hb-202/hb-201 phase 1 results in advanced hpv16+ hnscc patients: 80% dcr i.e. higher than #pembrolizumab in recurrent/metastatic (35% overall, 40% in hpv+ subset) 56% had tumor shrinkage #asco22 poster discussion in 1h in hall d2 
See my almost real-time Long & Short trades…. but do NOT consider my posts as #investing advice. Your #trading decisions are your own.